Literature DB >> 25640009

Genetic counselors' practices and confidence regarding variant of uncertain significance results and reclassification from BRCA testing.

C L Scherr1, N M Lindor2, T L Malo1, F J Couch3, S T Vadaparampil1.   

Abstract

Studies indicate variant of uncertain significance (VUS) results are challenging for genetic counselors and patients, often resulting in negative patient outcomes. Genetic counselors' current practices regarding VUS are unknown. This study utilized a national survey of genetic counselors (n = 932) to examine current practices and confidence related to disclosing BRCA VUS results and reclassification information. For participants (n = 398), descriptive statistics were calculated regarding patient demographic characteristics, practices and confidence, and cross tabulation was used to identify participant's actions when receiving a reclassified VUS. Upon receiving a BRCA VUS report, the majority reported providing patients with information about the frequency with which their VUS was seen and patient ancestry, but a minority discussed DNA banking. Most were confident in their understanding of, and ability to explain, VUS results to patients, but felt less confident about achieving high levels of patient understanding. Upon reclassification, the majority reported calling the patient and mailing the results, but when the reclassification was deleterious, the majority also met with the patient face-to-face. Given the lack of standard professional guidelines about informing patients of initial and reclassified VUS results, this overview provides important insight into genetic counselors' current practices and confidence.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  VUS reclassification; genetic counseling; genetic testing; hereditary cancer; variant of uncertain significance (VUS)

Mesh:

Substances:

Year:  2015        PMID: 25640009      PMCID: PMC4522387          DOI: 10.1111/cge.12563

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  34 in total

1.  Errors in delivery of cancer genetics services: implications for practice.

Authors:  Karina L Brierley; Danielle Campfield; Whitney Ducaine; Lindsay Dohany; Talia Donenberg; Kristen Shannon; Robin C Schwartz; Ellen T Matloff
Journal:  Conn Med       Date:  2010-08

2.  Multiplex genetic testing for cancer susceptibility: out on the high wire without a net?

Authors:  Susan M Domchek; Angela Bradbury; Judy E Garber; Kenneth Offit; Mark E Robson
Journal:  J Clin Oncol       Date:  2013-03-04       Impact factor: 44.544

3.  BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management.

Authors:  Noralane M Lindor; David E Goldgar; Sean V Tavtigian; Sharon E Plon; Fergus J Couch
Journal:  Oncologist       Date:  2013-04-24

4.  Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Authors:  Susan M Domchek; Tara M Friebel; Christian F Singer; D Gareth Evans; Henry T Lynch; Claudine Isaacs; Judy E Garber; Susan L Neuhausen; Ellen Matloff; Rosalind Eeles; Gabriella Pichert; Laura Van t'veer; Nadine Tung; Jeffrey N Weitzel; Fergus J Couch; Wendy S Rubinstein; Patricia A Ganz; Mary B Daly; Olufunmilayo I Olopade; Gail Tomlinson; Joellen Schildkraut; Joanne L Blum; Timothy R Rebbeck
Journal:  JAMA       Date:  2010-09-01       Impact factor: 56.272

5.  Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors.

Authors:  Bronson D Riley; Julie O Culver; Cécile Skrzynia; Leigha A Senter; June A Peters; Josephine W Costalas; Faith Callif-Daley; Sherry C Grumet; Katherine S Hunt; Rebecca S Nagy; Wendy C McKinnon; Nancie M Petrucelli; Robin L Bennett; Angela M Trepanier
Journal:  J Genet Couns       Date:  2011-12-02       Impact factor: 2.537

Review 6.  A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS).

Authors:  Noralane M Lindor; Lucia Guidugli; Xianshu Wang; Maxime P Vallée; Alvaro N A Monteiro; Sean Tavtigian; David E Goldgar; Fergus J Couch
Journal:  Hum Mutat       Date:  2011-11-03       Impact factor: 4.878

Review 7.  Failing to plan is planning to fail: improving the quality of care with survivorship care plans.

Authors:  Craig C Earle
Journal:  J Clin Oncol       Date:  2006-11-10       Impact factor: 44.544

8.  Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance.

Authors:  Andrew D Spearman; Kevin Sweet; Xiao-Ping Zhou; Jane McLennan; Fergus J Couch; Amanda Ewart Toland
Journal:  J Clin Oncol       Date:  2008-09-29       Impact factor: 44.544

9.  Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.

Authors:  Suzanne C O'Neill; Christine Rini; Rachel E Goldsmith; Heiddis Valdimarsdottir; Lawrence H Cohen; Marc D Schwartz
Journal:  Psychooncology       Date:  2009-10       Impact factor: 3.894

10.  Screening adherence in BRCA1/2 families is associated with primary physicians' behavior.

Authors:  Susan T Tinley; Julia Houfek; Patrice Watson; Lari Wenzel; Mary Beth Clark; Susan Coughlin; Henry T Lynch
Journal:  Am J Med Genet A       Date:  2004-02-15       Impact factor: 2.802

View more
  10 in total

1.  Current Approaches to Cancer Genetic Counseling Services for Spanish-Speaking Patients.

Authors:  Bianca Augusto; Monica L Kasting; Fergus J Couch; Noralane M Lindor; Susan T Vadaparampil
Journal:  J Immigr Minor Health       Date:  2019-04

Review 2.  Ethical considerations in genomic testing for hematologic disorders.

Authors:  Jonathan M Marron; Steven Joffe
Journal:  Blood       Date:  2017-06-09       Impact factor: 22.113

3.  From the laboratory to the clinic: sharing BRCA VUS reclassification tools with practicing genetics professionals.

Authors:  Bianca M Augusto; Paige Lake; Courtney L Scherr; Fergus J Couch; Noralane M Lindor; Susan T Vadaparampil
Journal:  J Community Genet       Date:  2017-11-09

4.  Lynch Syndrome Limbo: Patient Understanding of Variants of Uncertain Significance.

Authors:  Ilana Solomon; Elizabeth Harrington; Gillian Hooker; Lori Erby; Jennifer Axilbund; Heather Hampel; Kara Semotiuk; Amie Blanco; William M P Klein; Francis Giardiello; Lori Leonard
Journal:  J Genet Couns       Date:  2017-01-26       Impact factor: 2.537

5.  Perceptions and care Recommendations from Previvors: Qualitative analysis of female BRCA1/2 mutation Carriers' experience with genetic testing and counseling.

Authors:  Kate E Dibble; Laura K M Donorfio; Preston A Britner; Keith M Bellizzi
Journal:  Gynecol Oncol Rep       Date:  2022-05-02

6.  How does re-classification of variants of unknown significance (VUS) impact the management of patients at risk for hereditary breast cancer?

Authors:  Ava Kwong; Cecilia Yuen Sze Ho; Vivian Yvonne Shin; Chun Hang Au; Tsun-Leung Chan; Edmond Shiu Kwan Ma
Journal:  BMC Med Genomics       Date:  2022-05-31       Impact factor: 3.622

7.  Genetic Counselors' Experiences Regarding Communication of Reproductive Risks with Autosomal Recessive Conditions found on Cancer Panels.

Authors:  Sarah Mets; Rebecca Tryon; Patricia McCarthy Veach; Heather A Zierhut
Journal:  J Genet Couns       Date:  2015-10-10       Impact factor: 2.537

8.  Racial and Ethnic Disparities in Germline Genetic Testing of Patients With Young-Onset Colorectal Cancer.

Authors:  Pooja Dharwadkar; Garrett Greenan; Elena M Stoffel; Ezra Burstein; Sara Pirzadeh-Miller; Sayoni Lahiri; Caitlin Mauer; Amit G Singal; Caitlin C Murphy
Journal:  Clin Gastroenterol Hepatol       Date:  2020-12-24       Impact factor: 11.382

9.  Clinical validity assessment of genes for inclusion in multi-gene panel testing: A systematic approach.

Authors:  Tricia N Zion; Bess Wayburn; Sourat Darabi; Devon Lamb Thrush; Erica D Smith; Tami Johnston; Brissa Martin; Kelly D F Hagman; Melissa Parra; Christian Antolik
Journal:  Mol Genet Genomic Med       Date:  2019-03-21       Impact factor: 2.183

10.  Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients.

Authors:  Ozge Ceyhan-Birsoy; Gowtham Jayakumaran; Yelena Kemel; Maksym Misyura; Umut Aypar; Sowmya Jairam; Ciyu Yang; Yirong Li; Nikita Mehta; Anna Maio; Angela Arnold; Erin Salo-Mullen; Margaret Sheehan; Aijazuddin Syed; Michael Walsh; Maria Carlo; Mark Robson; Kenneth Offit; Marc Ladanyi; Jorge S Reis-Filho; Zsofia K Stadler; Liying Zhang; Alicia Latham; Ahmet Zehir; Diana Mandelker
Journal:  Genome Med       Date:  2022-08-15       Impact factor: 15.266

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.